Theme: Exploring the novel research and innovations in Cell & gene therapy

Cell Therapy 2017
Past Report of Cell Therapy-2015

Cell Therapy 2017

Track-1 Cell Therapy:

Cell therapy as performed by alternative medicine practitioners is very different from the controlled research done by conventional stem cell medical researchers. Alternative practitioners refer to their form of cell therapy by several other different names including xenotransplanttherapyglandular therapy, and fresh cell therapy. Proponents of cell therapy claim that it has been used successfully to rebuild damaged cartilage in joints, repair spinal cord injuries,strengthen a weakened immune system, treat autoimmune diseases such as AIDS, and help patients with neurological disorders such as Alzheimer’s disease, Parkinson's disease and epilepsy.

Related Cell Therapy Conferences | Cell Therapy |Gene Therapy Conferences | Conference Series LLC

6th International Conference on Tissue Engineering & Regenerative Medicine, Baltimore, USA, Aug 20-22, 2017; 8th World Congress and Expo on Cell & Stem Cell ResearchOrlando, USA, March 20-22, 2017; 15th World Congress on Biotechnology and Biotech Industries Meet, Rome, Italy, March 20-21,2017; 2nd International Conference on Genetic Counselling and Genomic MedicineBeijing, China,July 10-12, 2017; International Conference on Clinical and Molecular Genetics, Las Vegas, USA, April 24-26, 2017.

Track-2 Gene therapy:

Gene therapy and cell therapy are overlapping fields of biomedical research with the goals of repairing the direct cause of genetic diseases in the DNA or cellular population, respectively. The development of suitable gene therapy treatments for many genetic diseases and some acquired diseases has encountered many challenges and uncovered new insights into gene interactions and regulation. Further development often involves uncovering basic scientific knowledge of the affected tissues, cells, and genes, as well as redesigning vectors, formulations, and regulatory cassettes for the genes. Cell therapy is expanding its repertoire of cell types for administration. Cell therapy treatment strategies include isolation and transfer of specific stem cell populations, administration of effector cells, and induction of mature cells to become pluripotent cells, and reprogramming of mature cells.

Related Cell Therapy Conferences | Cell Therapy |Gene Therapy Conferences | Conference Series LLC

2nd International Conference on Molecular Biology , London, UKJune 22-24, 2017; 3rd World Bio Summit & Expo, Abu Dhabi, UAE, June 19-21, 2017; 5th International Conference on Integrative Biology, London, UK, June 19-21, 2017; 2nd World Congress on Human Genetics, Chicago, USA, July 24-26, 2017; 9th International Conference on Genomics and Pharmacogenomics, Chicago, USA, July 13-14, 2017.

Track-3 Cell and gene therapy products:

Articles containing or consisting of human cells or tissues that are intended for implantation, transplantation, infusion, or transfer to a human recipient. Gene therapies are novel and complex products that can offer unique challenges in product development. Hence, ongoing communication between the FDA and stakeholders is essential to meet these challenges. Gene therapy products are being developed around the world, the FDA is engaged in a number of international harmonization activities in this area.

Examples: Musculoskeletal tissue, skin, ocular tissue, human heart valves; vascular graft, dura mater, reproductive tissue/cells, Stem/progenitor cells ,somatic cells, Cells transduced with gene therapy vectors , Combination products (e.g., cells or tissue + device)

Related Cell Therapy Conferences | Cell Therapy |Gene Therapy Conferences | Conference Series LLC

7th International Conference on Plant Genomics, Bangkok, Thailand, July 03-05, 2017; 15th Euro Biotechnology Congress, Valencia, Spain, June 05-07, 2017; International Conference on Integrative Medicine & Nutrition, Dubai, UAE, May11-13, 2017; 14th Asia-Pacific Biotech Congress, April 10-12, 2017; Beijing, China,15th Biotechnology Congress, Baltimore, USA, June 22-23, 2017.

Track-4 Cellular therapy:

Cellular therapy, also called live cell therapy, cellular suspensions, glandular therapy, fresh cell therapy, sick cell therapy, embryonic cell therapy, and organ therapy - refers to various procedures in which processed tissue from animal embryos, foetuses or organs, is injected or taken orally. Products are obtained from specific organs or tissues said to correspond with the unhealthy organs or tissues of the recipient. Proponents claim that the recipient's body automatically transports the injected cells to the target organs, where they supposedly strengthen them and regenerate their structure. The organs and glands used in cell treatment include brain, pituitary, thyroid, adrenals, thymus, liver, kidney, pancreas, spleen, heart, ovary, testis, and parotid. Several different types of cell or cell extract can be given simultaneously - some practitioners routinely give up to 20 or more at once.

Related Cell Therapy Conferences | Cell Therapy |Gene Therapy Conferences | Conference Series LLC

3rd International Conference on Synthetic Biology, Munich, Germany, July 20-21, 2017;  5th International Conference and Exhibition on Cell and Gene Therapy, Madrid, Spain,Mar 2-3, 2017; International Conference on Cell Signalling and Cancer TherapyParis, France, Aug 20-22, 2017;  7th Annual Conference on Stem Cell and Regenerative Medicine, Paris, France, Aug 04-05, 2016; 3rd International Conference & Exhibition on Tissue Preservation and Bio banking, Baltimore, USA,June 29-30, 2017.

Track-5 Cancer gene therapy:

Cancer therapies are drugs or other substances that block the growth and spread of cancer by interfering with specific molecules ("molecular targets") that are involved in the growth, progression, and spread of cancer. Many cancer therapies have been approved by the Food and Drug Administration (FDA) to treat specific types of cancer. The development of targeted therapies requires the identification of good targets that is, targets that play a key role in cancer cell growth and survival. One approach to identify potential targets is to compare the amounts of individual proteins in cancer cells with those in normal cells.  Proteins that are present in cancer cells but not normal cells or that are more abundant in cancer cells would be potential targets, especially if they are known to be involved in cell growth or survival.

Related Cell Therapy Conferences | Cell Therapy |Gene Therapy Conferences | Conference Series LLC

2nd Biotechnology World Convention, London, UK, May 25-27, 2017;  International Conference on Animal and Human Cell Culture, Jackson Ville, USA, Sep 25-27, 2017; 9th International Conference on Cancer Genomics, Chicago, USA, May 29-31, 2017; 6th International Conference on Tissue Engineering & Regenerative Medicine, Baltimore, USA, Aug 20-22, 2017; 8th World Congress and Expo on Cell & Stem Cell Research, Orlando, USA, March 20-22, 2017.

Track-6 Nano therapy:

Nano Therapy may be defined as the monitoring, repair, construction and control of human biological systems at the molecular level, using engineered nanodevices and nanostructures. Basic nanostructured materials, engineered enzymes, and the many products of biotechnology will be enormously useful in near-term medical applications. However, the full promise of nanomedicine is unlikely to arrive until after the development of precisely controlled or programmable medical Nano machines and nanorobots.

Related Cell Therapy Conferences | Cell Therapy |Gene Therapy Conferences | Conference Series LLC

15th World Congress on Biotechnology and Biotech Industries Meet ,Rome, Italy,March 20-21, 2017 2nd International Conference on Genetic Counselling and Genomic Medicine ,Beijing, China, July 10-12, 2017;  International Conference on Clinical and Molecular Genetics, Las Vegas, USA, April 24-26, 2017; 15th Euro Biotechnology Congress, Valencia, Spain, June 05-07, 2017; International Conference on Integrative Medicine & Nutrition, Dubai, UAE, May11-13, 2017.

Track-7 Skin cell therapy:

Stem cells have newly become a huge catchphrase in the skincare biosphere. Skincare specialists are not using embryonic stem cells; it is impossible to integrate live materials into a skincare product.  Instead, scientists are creating products with specialized peptides and enzymes or plant stem cells which, when applied topically on the surface, help to protect the human skin stem cells from damage and deterioration or stimulate the skins own stem cells. Currently, the technique is mainly used to save the lives of patients who have third degree burns over very large areas of their bodies.

Related Cell Therapy Conferences | Cell Therapy |Gene Therapy Conferences | Conference Series LLC

5th International Conference and Exhibition on Cell and Gene TherapyMadridSpain, Mar 2-3, 2017; International Conference on Cell Signalling and Cancer Therapy,Paris, France, Aug 20-22, 2017; 2nd Biotechnology World Convention, London, UK, May 25-27, 2017; International Conference on Animal and Human Cell Culture, Jackson Ville, USA, Sep 25-27, 2017; 9th International Conference on Cancer Genomics, Chicago, USA, May 29-31, 2017.

Track-8 HIV gene therapy:

Highly active antiretroviral therapy dramatically improves survival in HIV-infected patients. However, persistence of HIV in reservoirs has necessitated lifelong treatment that can be complicated by cumulative toxicities, incomplete immune restoration, and the emergence of drug-resistant escape mutants. Cell and gene therapies offer the promise of preventing progressive HIV infection by interfering with HIV replication in the absence of chronic antiviral therapy.

 

Related Cell Therapy Conferences | Cell Therapy |Gene Therapy Conferences | Conference Series LLC

3rd International Conference on Synthetic Biology, Munich, Germany, July 20-21, 2017;  International Conference on Integrative Medicine & Nutrition, Dubai, UAE, May11-13, 2017; International Conference on Animal and Human Cell Culture, Jackson Ville, USA, Sep 25-27, 2017; International Conference on Cell Signalling and Cancer TherapyParis, France,Aug 20-22, 2017; 7th Annual Conference on Stem Cell and Regenerative Medicine, ParisFrance, Aug 04-05, 2016.

Track-9 Diabetes for gene therapy:

Cell therapy approaches for this disease are focused on developing the most efficient methods for the isolation of pancreas beta cells or appropriate stem cells, appropriate location for cell transplant, and improvement of their survival upon infusion. Alternatively, gene and cell therapy scientists are developing methods to reprogram some of the other cells of the pancreas to secrete insulin. Currently ongoing clinical trials using these gene and cell therapy strategies hold promise for improved treatments of type I diabetes in the future. The first gene therapy approach to diabetes was put forward shortly after the cloning of the insulin gene. It was proposed that non-insulin producing cells could be made into insulin-producing cells using a suitable promoter and insulin gene construct, and that these substitute cells could restore insulin production in type 1 and some type 2 diabetics. 

Related Cell Therapy Conferences | Cell Therapy |Gene Therapy Conferences | Conference Series LLC

15th World Congress on Biotechnology and Biotech Industries Meet ,Rome, Italy, March 20-21, 2017;  6th International Conference on Tissue Engineering & Regenerative Medicine, Baltimore, USA, Aug 20-22, 2017; 8th World Congress and Expo on Cell & Stem Cell Research, Orlando, USA, March 20-22, 2017;  14th Asia-Pacific Biotech Congress, Beijing, China, April 10-12, 2017;  5th International Conference on Integrative Biology, London, UK, June 19-21, 2017.

Track-10 Viral gene therapy:

Converting a virus into a vector The viral life cycle can be divided into two temporally distinct phases: infection and replication. For gene therapy to be successful, an appropriate amount of a therapeutic gene must be delivered into the target tissue without substantial toxicity. Each viral vector system is characterized by an inherent set of properties that affect its suitability for specific gene therapy applications. For some disorders, long-term expression from a relatively small proportion of cells would be sufficient (for example, genetic disorders), whereas other pathologies might require high, but transient, gene expression. For example, gene therapies designed to interfere with a viral infectious process or inhibit the growth of cancer cells by reconstitution of inactivated tumour suppressor genes may require gene transfer into a large fraction of the abnormal cells.

Related Cell Therapy Conferences | Cell Therapy |Gene Therapy Conferences | Conference Series LLC

3rd International Conference on Synthetic Biology, Munich, Germany, July 20-21, 2017; 5th International Conference and Exhibition on Cell and Gene Therapy,Madrid, Spain, Mar 2-3, 2017;  International Conference on Animal and Human Cell Culture, Jackson Ville, USA, Sep 25-27, 2017;  9th International Conference on Cancer Genomics, Chicago, USA, May 29-31, 2017;  14th Asia-Pacific Biotech Congress, Beijing, China, April 10-12, 2017.

Track-11 Stem cell therapies: 

Stem cells   have tremendous promise to help us understand and treat a range of diseases, injuries and other health-related conditions. Their potential is evident in the use of blood stem cells to treat diseases of the blood, a therapy that has saved the lives of thousands of children with leukaemia; and can be seen in the use of stem cells for tissue grafts to treat diseases or injury to the bone, skin and surface of the eye. Some bone, skin and corneal (eye) injuries and diseases can be treated by grafting or implanting tissues, and the healing process relies on stem cells within this implanted tissue.  

Related Cell Therapy Conferences | Cell Therapy |Gene Therapy Conferences | Conference Series LLC

2nd World Congress on Human Genetics, Chicago, USA, July 24-26, 2017; 2nd International Conference on Genetic Counselling and Genomic Medicine ,Beijing, China, July 10-12, 2017;  International Conference on Clinical and Molecular Genetics, Las Vegas, USA, April 24-26, 2017; 2nd International Conference on Molecular Biology ,London, UK, June 22-24, 2017; 15th Biotechnology Congress, Baltimore, USA, June 22-23, 2017.

Track-12 Stem cell preservation:

The ability to preserve the cells is critical to their clinical application. It improves patient access to therapies by increasing the genetic diversity of cells available. In addition, the ability to preserve cells improves the "manufacturability" of a cell therapy product by permitting the cells to be stored until the patient is ready for administration of the therapy, permitting inventory control of products, and improving management of staffing at cell therapy facilities. Finally, the ability to preserve cell therapies improves the safety of cell therapy products by extending the shelf life of a product and permitting completion of safety and quality control testing before release of the product for use. preservation permits coordination between the manufacture of the therapy and patient care regimes.

Related Cell Therapy Conferences | Cell Therapy |Gene Therapy Conferences | Conference Series LLC

7th Annual Conference on Stem Cell and Regenerative Medicine,Paris, France, Aug 04-05, 2016;  2nd Biotechnology World Convention,LONDON, UK, May 25-27, 2017; International Conference on Animal and Human Cell Culture, Jackson Ville, USA, Sep 25-27, 2017; 9th International Conference on Cancer Genomics, Chicago, USA, May 29-31, 2017;  3rd International Conference on Synthetic Biology, Munich, Germany, July 20-21, 2017.

Track-13 Stem cell products:

The global stem cell, Stem cell products market will grow from about $5.6 billion in 2013 to nearly $10.6 billion in 2018, registering a compound annual growth rate (CAGR) of 13.6% from 2013 through 2018.This track discusses the implications of stem cell research and commercial trends in the context of the current size and growth of the pharmaceutical market, both in global terms and analysed by the most important national markets.

Related Cell Therapy Conferences | Cell Therapy |Gene Therapy Conferences | Conference Series LLC

6th International Conference on Tissue Engineering & Regenerative Medicine, Baltimore, USA, Aug 20-22, 2017; 8th World Congress and Expo on Cell & Stem Cell Research, Orlando, USA, March 20-22, 2017; 15th World Congress on Biotechnology and Biotech Industries Meet, Rome, Italy, March 20-21, 2017; 2nd International Conference on Genetic Counselling and Genomic MedicineBeijing, China, July 10-12, 2017; International Conference on Clinical and Molecular Genetics, las vegas, USA, April 24-26, 2017.

Track-14 Genetically inherited diseases:

genetic disease is any disease that is caused by an abnormality in an individual's genome, the person's entire genetic makeup. The abnormality can range from minuscule to major -- from a discrete mutation in a single base in the DNA of a single gene to a gross chromosome abnormality involving the addition or subtraction of an entire chromosome or set of chromosomes. Most genetic diseases are the direct result of a mutation in one gene. However, one of the most difficult problems ahead is to find out how genes contribute to diseases that have a complex pattern of inheritance, such as in the cases of diabetes, asthma, cancer and mental illness. In all these cases, no one gene has the yes/no power to say whether a person has a disease or not. It is likely that more than one mutation is required before the disease is manifest, and a number of genes may each make a subtle contribution to a person's susceptibility to a disease; genes may also affect how a person reacts to environmental factors.

Related Cell Therapy Conferences | Cell Therapy |Gene Therapy Conferences | Conference Series LLC

15th Biotechnology Congress, Baltimore, USA, June 22-23, 2017; 3rd International Conference on Synthetic Biology, Munich, Germany, July 20-21, 2017; 5th International Conference and Exhibition on Cell and Gene TherapyMadrid, Spain, Mar 2-3, 2017;  International Conference on Cell Signalling and Cancer Therapyparis, France, Aug 20-22, 2017;  International Conference on Animal and Human Cell Culture, Jackson Ville, USA, Sep 25-27, 2017.

Track-15 Plant stem cells:

Plants have emerged as powerful production platforms for the expression of fully functional recombinant mammalian proteins. These expression systems have demonstrated the ability to produce complex glycoproteins in a cost-efficient manner at large scale. The full realization of the therapeutic potential of stem cells has only recently come into the forefront of regenerative medicine. Stem cells are unprogrammed cells that can differentiate into cells with specific functions. Regenerative therapies are used to stimulate healing and might be used in the future to treat various kinds of diseases. Regenerative medicine will result in an extended healthy life span. A fresh apple is a symbol for beautiful skin. Hair greying for example could be shown to result from the fact that the melanocyte stem cells in the hair follicle have died off.

Related Cell Therapy Conferences | Cell Therapy |Gene Therapy Conferences | Conference Series LLC

9th International Conference on Genomics and Pharmacogenomics, Chicago, USA, July 13-14, 2017; 7th International Conference on Plant Genomics, Bangkok, Thailand, July 03-05, 2017; 15th Euro Biotechnology Congress, Valencia, Spain, June 05-07, 2017; 5th International Conference and Exhibition on Cell and Gene TherapyMadrid, Spain, Mar 2-3, 2017; 3rd International Conference & Exhibition on Tissue Preservation and Bio banking, Baltimore, USA, June 29-30, 2017.

Track-16 Plant stem cell rejuvenation:

As plants cannot escape from danger by running or taking flight, they need a special mechanism to withstand environmental stress. What empowers them to withstand harsh attacks and preserve life is the stem cell. According to Wikipedia, “plant stem cells never undergo the aging process but constantly create new specialized and unspecialized cells, and they have the potential to grow into any organ, tissue, or cell in the body.” The everlasting life is due to the hormones auxin and gibberellin. British scientists found that plant stem cells were much more sensitive to DNA damage than other cells. And once they sense damage, they trigger death of these cells.

Rejuvenate with Plant Stem Cells

Detoxify and release toxins on a cellular level.
Nourish your body with vital nutrients.
Regenerate your cells and diminish the effects of aging. 

Related Cell Therapy Conferences | Cell Therapy |Gene Therapy Conferences | Conference Series LLC

International Conference on Animal and Human Cell Culture, Jackson Ville, USA, Sep 25-27, 2017; 14th Asia-Pacific Biotech Congress, Beijing, China, April 10-12, 2017; 15th Biotechnology Congress, Baltimore, USA, June 22-23, 2017; 3rd International Conference on Synthetic Biology, Munich, Germany,July 20-21, 2017; 5th International Conference and Exhibition on  Cell and Gene TherapyMadrid, Spain, Mar 2-3, 2017.

Track-17 Clinical trials in cell and gene therapy:

clinical trial is a research study that seeks to determine if a treatment is safe and effective. Advancing new cell and gene therapies (CGTs) from the laboratory into early-phase clinical trials has proven to be a complex task even for experienced investigators. Due to the wide variety of CGT products and their potential applications, a case-by-case assessment is warranted for the design of each clinical trial.

Objectives: Determine the pharmacokinetics of this regimen by the persistence of modified T cells in the blood of these patients, Evaluate the immunogenicity of murine sequences in chimeric anti-CEA Ig TCR, Assess immunologic parameters which correlate with the efficacy of this regimen in these patients, Evaluate, in a preliminary manner, the efficacy of this regimen in patients with CEA bearing tumours.

Related Cell Therapy Conferences | Cell Therapy |Gene Therapy Conferences | Conference Series LLC

2nd Biotechnology World Convention, London, UK, May 25-27, 2017; International Conference on Animal and Human Cell Culture, Jackson Ville, USA, Sep 25-27, 2017; 9th International Conference on Cancer Genomics, Chicago, USA, May 29-31, 2017;  8th World Congress and Expo on Cell & Stem Cell Research, Orlando, USA, March 20-22, 2017; 15th World Congress on Biotechnology and Biotech Industries Meet, Rome, Italy, March 20-21, 2017.

Track-18 Molecular epigenetics:

Epigenetics is the study of heritable changes in the phenotype of a cell or organism that are not caused by its genotype. The molecular basis of an epigenetic profile arises from covalent modifications of protein and DNA components of chromatin. The epigenetic profile of a cell often dictates cell fate, as well as mammalian development, aging and disease. Epigenetics has evolved to become the science that explains how the differences in the patterns of gene expression in diverse cells or tissues are executed and inherited.

Related Cell Therapy Conferences | Cell Therapy |Gene Therapy Conferences | Conference Series LLC

5th International Conference on Integrative Biology, London, UK, June 19-21, 2017; 2nd World Congress on Human Genetics, Chicago, USA, July 24-26, 2017; 9th International Conference on Genomics and Pharmacogenomics, Chicago, USA, July 13-14, 2017;  International Conference on Integrative Medicine & Nutrition, Dubai, UAE, May11-13, 2017; 14th Asia-Pacific Biotech Congress,Beijing, China, April 10-12, 2017.

Track-19 Bioengineering therapeutics:

The goals of bioengineering strategies for targeted cancer therapies are (1) to deliver a high dose of an anticancer drug directly to a cancer tumour, (2) to enhance drug uptake by malignant cells, and (3) to minimize drug uptake by non-malignant cells. In ESRD micro electro mechanical systems and nanotechnology to create components such as robust silicon Nano pore filters that mimic natural kidney structure for high-efficiency toxin clearance. It also uses tissue engineering to build a miniature bioreactor in which immune-isolated human-derived renal cells perform key functions, such as reabsorption of water and salts. In drug delivery for a leading cause of blindness, photo-etching fabrication techniques from the microchip industry to create thin-film and planar micro devices (dimensions in millionths of meters) with protective medication reservoirs and nanopores (measured in billionths of meters) for insertion in the back of the eye to deliver sustained doses of drug across protective retinal epithelial tissues over the course of several months.

Related Cell Therapy Conferences | Cell Therapy |Gene Therapy Conferences | Conference Series LLC

6th International Conference on Tissue Engineering & Regenerative Medicine, Baltimore, USA, Aug 20-22, 2017; 8th World Congress and Expo on Cell & Stem Cell Research, Orlando, USA, March 20-22, 2017; 15th World Congress on Biotechnology and Biotech Industries Meet, Rome, Italy, March 20-21, 2017; 2nd International Conference on Genetic Counselling and Genomic MedicineBeijing, China, July 10-12, 2017; International Conference on Clinical and Molecular Genetics, Las Vegas, USA, April 24-26, 2017.

Track-20 Advanced gene therapy:

Advanced therapies are different from conventional medicines, which are made from chemicals or proteins. Gene-therapy medicines: these contain genes that lead to a therapeutic effect. They work by inserting 'recombinant' genes into cells, usually to treat a variety of diseases, including genetic disorders, cancer or long-term diseases. Somatic-cell therapy medicines: these contain cells or tissues that have been manipulated to change their biological characteristics. Advanced Cell & Gene Therapy provides guidance in process development, GMP/GTP manufacturing, regulatory affairs, due diligence and strategy, specializing in cell therapy, gene therapy, and tissue-engineered regenerative medicine products.

Related Cell Therapy Conferences | Cell Therapy |Gene Therapy Conferences | Conference Series LLC

9th International Conference on Genomics and Pharmacogenomics, Chicago, USA, July 13-14, 2017; 7th International Conference on Plant Genomics, Bangkong,Thailand, July 03-05, 2017; International Conference on Integrative Medicine & Nutrition, Dubai, UAE, May11-13, 2017; 14th Asia-Pacific Biotech Congress, Beijing,ChinaApril 10-12, 2017;  2nd World Congress on Human Genetics, Chicago, USA, July 24-26, 2017.

 

ConferenceSeries LLC welcomes you to attend the 6th International Conference and Exhibition on Cell & Gene Therapy during March 2-3, 2017 at Madrid,Spain. We cordially invite all the participants who are interested in sharing their knowledge and research in the arena of Cell & Gene Therapy.

Cell and Gene Therapy Conference is to ameliorate the knowledge, awareness, and education on cell and gene therapy leading to the discovery of genetic and cellular therapies which aid to alleviate the human disease as it is the most significant emerging technology in the eyes of Medical, Biotechnology, Pharmaceuticals and Academia. Cell and Gene Therapy Conference 2017 is an excellent opportunity for the delegates from Universities and Institutes to interact with the world class Scientists.

Cell Therapy Conferences will provide a perfect platform to all the Doctors, Researchers Business Delegates and Scientists to approach and deliver all the attendees about the latest scientific advancements on the respective sphere.

Gene Therapy Conferences strategic astuteness is to be an event for bringing together Scientists, Physicians, International mix of leading Universities, Cell Gene Therapy Institutions to transform the practice of medicine by incorporating the use of genetic and cellular therapies to control and cure human disease.

This two-day Gene Therapy Event will address key issues concerning cell and gene therapy in the broader context of cellular and genetic disorder. Organized around daily themes, the Conference focuses on moving from present knowledge to future solutions

Global markets for stem cells by BCC Research (2012), cited by Ministry of Food and Drug Safety, predicted the global market size of stem cell therapy product would be 6.6 billion dollars in 2016 and grow 11.7% on average every year. Currently, Europe cell therapy and gene therapy occupy share market of  872 million dollars. Europe's is 10.9% (1.5 billion dollars in 2016).

OMICS International Organises 300+ International Conferences Every Year across Europe,USA & Asia with support from 1000 more scientific societies and Publishes 400+ Open access journals which contains over 30000 eminent personalities, reputed scientists as editorial board members.

The previous conferences on Cell & Gene Therapy which were held at San Antonio, USA and London, UK have explained Research & Advancements in Cell and Gene Therapy, gained so much of interest for eminent scientists all over the world in the field of Cell & Gene Therapy. Now it is the time for the 6th International Conference and Exhibition on Cell & Gene Therapy to address Exploring the novel research and innovations in Cell and Gene therapy  which will be held on March 2-3,2017 at Madrid, Spain.

Target Audience

Cell and Gene Therapy Students, Scientists

Cell and Gene Therapy Researchers

Cell and Gene Therapy Faculty

Cell and Gene Therapy Associations and Societies

Cell and Gene Therapy physicians

Cell and Gene Therapy advanced practice registered nurses,

Allied health professionals in the fields of Cell and Gene Therapy,hematology, oncology, neurology, family medicine and internal medicine.

Stem Cell Students, Scientists

Stem Cell Researchers

Stem Cell Faculty

Stem Cell Associations and Societies

Business Entrepreneurs

Training Institutes

Software developing companies

Cell Therapy 2016

OMICS International Conferences successfully hosted its premier 5th International Conference and Exhibition on Cell and Gene Therapy during May19-21, 2016 at Hilton San Antonio Airport, San Antonio, USA

 

The conference brought together a comprehensive range of the cell and gene therapy researchers, educators from research universities as well as representatives from industry and professional cell and gene therapy societies.

 

Cell Therapy-2016 is known for uplifting the future of cell and gene therapy and its allied areas by encouraging students and fellow researchers to present their work through poster presentations and young research forum. Students participated with great zeal and the best posters were awarded for their efforts and outstanding contribution to the cell and gene therapy research.

 

OMICS International Conferences wishes to acknowledge with its deep sincere gratitude to all the supporters from the Editorial Board Members of our Open Access Journals, Keynote speakers, Honourable guests, valuable speakers, poster presenters, students, delegates and special thanks to the media partners, Exhibitors for their promotion to make this event a huge success.

 

This 5th International Conference and Exhibition on Cell and Gene Therapy based on the theme “Frontiers in Cell and Gene Therapy: From Bench to Bedside” which covered the below scientific sessions like Gene Therapy, Cell and Gene Therapy Products, Cellular Therapy, Cancer Gene Therapy, Nano Therapy, Skin Cell Therapy, HIV Gene Therapy, Diabetes for Gene Therapy, Viral Gene Therapy, Stem Cell Therapies, Stem Cell Preservation, Stem Cell Products, Genetically Inherited diseases, Plant Stem Cells, Plant Stem Cell Rejuvenation, Clinical Trials in Cell & Gene Therapy, Molecular Epigenetics, Bioengineering Therapeutics, Advanced Gene Therapeutics, Ethical Issues of Therapies,.

 

The conference was greeted by the conference Moderator: Dr. Juliann G. Kiang, Uniformed Services University of The Health Sciences, USA. The support was extended by the Keynote Speaker: Dr. Vikas Kundra, MD Anderson Cancer Centre, USA; Dr. Jennifer Grinnell, Biosheprix, USA; Dr. Heidi Strona, PeproTech, USA

 

 

 

OMICS International acknowledges the support of below Chairs and Co-chairs with whom we were able to run the scientific sessions smoothly it included: Dr. Chan-Wha Kim, Korea University College of Life Sciences and biotechnology, Korea; Dr. Juliann G Kiang, Uniformed Services University of The Health Sciences, USA; Dr. Michail Ponizovskiy, Kiev regional p/n hospital, Germany.

 

This 5th International Conference and Exhibition on Cell and Gene Therapy was uplifted with more than 32 oral presentations by researchers, scientists, professors, industry delegates and more than 15 poster participants around the globe. OMICS International has taken the privilege of felicitating Cell Therapy-2016 Organizing Committee Members, Editorial Board Members of the supported Journals and Keynote Speakers who supported for the success of this event


Past Reports  Gallery  

Click here to submit abstract to any of the above topics

sponsor

Want to Differentiate your company from your competitors and broaden your competitive edge?

Use our global platform of 3000+ Global Events

  • 25 Million+ Visitors to our Global website (conferenceseries.com)
  • 20000+ Unique Visitors per conference
  • 60000+ Page views per conference

For customized sponsorship opportunities at our conferences, or to place an ad on our websites, contact at sponsors@conferenceseries.com or call at: +1-650-268-9744

To share your views and research, please click here to register for the Conference.

To Collaborate Scientific Professionals around the World

Conference Date Mar 2-3, 2017
Sponsors & Exhibitors Click here for Sponsorship Opportunities
Speaker Opportunity
Poster Opportunity Available

Media Partners

Conferenceseries Destinations